BioCorRx (BICX) EBITDA Margin Growth (3y) (2014 - 2026)
Analysis
BioCorRx (BICX) EBITDA Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | -482.00 |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 1,479.00 |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 115.00 |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 278.00 |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 324.00 |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 5.00 |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 54.00 |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 114.00 |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 141.00 |
| 10 | BioCorRx | 3.46 Mn | 3.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 215,178.00 |
| Dec 31, 2025 | 177,178.00 |
| Sep 30, 2025 | 77,670.00 |
| Jun 30, 2025 | 765,666.00 |
| Mar 31, 2025 | 475,689.00 |
| Jun 30, 2024 | -2.76 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | 360,780.00 |
| Sep 30, 2023 | -255,499.00 |
| Jun 30, 2023 | 157,735.00 |
| Mar 31, 2023 | 150,273.00 |
| Dec 31, 2022 | 112,375.00 |
| Sep 30, 2022 | 80,780.00 |
| Jun 30, 2022 | -602,770.00 |
| Mar 31, 2022 | -318,482.00 |
| Dec 31, 2021 | -598,219.00 |
| Sep 30, 2021 | -1.67 Mn |
| Jun 30, 2021 | -532,218.00 |
| Mar 31, 2021 | -1.52 Mn |
| Dec 31, 2020 | -729,550.00 |